Nanofiltration removal of pharmaceutically active compounds

Desalination and Water Treatment

Volumn 42, Issue 1-3, 2012, Pages 138-143

  López Muñoz, María José ^a   Sotto, Arcadio ^a   Arsuaga, Jesús M ^a  

^a UNIVERSIDAD REY JUAN CARLOS   (Spain)

Author keywords

4 Acetamidoautipyrine; Diclofenac; Hydrochlorothiazide; Nanofiltration; Nictoine; Pharmaceutical; Ranitidine; Sulfamethoxazole; Water treatment

Indexed keywords

EID: 85025315404     PISSN: 19443994     EISSN: 19443986     Source Type: Journal    
DOI: 10.1080/19443994.2012.683099     Document Type: Article

References (20)

1. T. Heberer, Occurrence, fate, and removal of pharmaceuti cal residues in the aquatic environment: a review of recent research data, Toxicol. Lett., 131 (2002) 5-17.
2. L.D. Nghiem, A. Schäfer and M. Elimelech, Role of electro static interactions in the retention of pharmaceutically active contaminants by a loose nanofiltration membrane, J. Membr. Sci., 286 (2006) 52-59.
3. M. Clara, B. Strenn, O. Gans, E. Martinez, N. Kreuzinger and H. Kroiss, Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants, Water Res., 39 (2005) 4797-4807.
4. C. Miège, J. Choubert, L. Ribeiro, M. Eusèbe and M. Coquery, Fate of pharmaceuticals and personal care products in wastewater treatment plants. Conception of a database and first results, Environ. Pollut., 157 (2009) 1721-1726.
5. B. Bozkaya-Schrotter, C. Daines, J.-C. Schrotter and P. Breant, Treatment of nanofiltration membrane concentrates: organic micropollutant and NOM removal, Desalin. Water Treat., 9 (2009) 36-42.
6. A.R.D. Verliefde, E.R. Cornelissen, S.G.J. Heijman, I. G. Amy, B. van der Bruggen and C. van Dijk, Influence of membrane fouling by (pretreated) surface water on rejection of pharmaceutically active compounds (PhACs) by nanofiltration membranes, J. Membr. Sci., 330 (2007) 90-103.
7. M. Cakmakci, A.B. Baspinar, U. Balaban, V. Uyak, I. Koyuncu and C. Kinaci, Comparison of nanofiltration and adsorption techniques to remove arsenic from drinking water, Desalin. Water Treat., 9 (2009) 149-154.
8. H. Ozaki, N. Ikejima, Y. Shimizu, K. Fukami, S. Taniguchi, R. Takanami, R.R. Giri and S. Matsui, Rejection of reverse osmosis membranes, Water Sci. Technol., 58 (2008) 73-81.
9. A. Sotto, M.J. López-Muñoz, J.M Arsuaga, J. Aguado and A. Revilla, Membrane treatment applied to aqueous solutions containing atrazine photocatalytic oxidation products, Desalin. Water Treat., 21 (2010) 175-180.
10. R. Ma, Y. Xie, B. Xu, B. Dong and N. Gao, Ametryn removal with nanofiltration membranes, Desalin. Water Treat., 29 (2011) 331-335.
11. K. Boussu, C. Vandecasteele and B. van der Bruggen, Relation between membrane characteristics and performance in nanofiltration, J. Membr. Sci., 310 (2008) 51-65.
12. E. Drazevic, K. Kosutic, S. Fingle and V. Drevenkar, Removal of pesticides from the water and their adsorption on the reverse osmosis membranes of defined porous structure, Desalin. Water Treat., 30 (2011) 161-170.
13. M.J. López-Muñoz, A. Sotto, J.M. Arsuaga and B. an der Bruggen, Influence of membrane, solute and solution properties on the retention of phenolic compounds in aqueous solution by nanofiltration membranes, Sep. Purif. Technol., 66 (2009) 194-201.
14. E. Ellouze, S. Souissi, A. Jrad, R. Ben Amar and A. Ben Salah, Per formances of nanofiltration and reverse osmosis in textile industry waste water treatment, Desalin. Water Treat., 22 (2010) 182-186.
15. L.D. Nghiem, A. Schäfer and M. Elimelech, Pharmaceutical retention mechanism by nanofiltration membranes, Environ. Sci. Technol., 39 (2005) 7698-7705.
16. A. Simon, L.D. Nghiem, P. Le-Clech, S. Khan and J. Drewes, Effects of membrane degradation on the removal of pharmaceutically active compounds (PhACs) by NF/RO filtration processes, J. Membr. Sci., 340 (2009) 16-25.
17. A. Verliefde, S. Heijman, E. Cornelissen, G Amy, B. van der Bruggen and C. van Dijk, Influence of electrostatic interactions on the rejection with NF and assessment of the removal effi ciency during NF/GAC treatment of pharmaceutically active compounds in surface water, Water Res., 41 (2009) 3227-3240.
18. L. Braeken, R. Ramaekers, Y. Zhang, G. Maes, B. van der Bruggen and C. Vandecasteele, (2005). Influence of hydrophobicity on retention in nanofiltration of aqueous solutions containing organic compounds, J. Membr. Sci., 252 (2005) 195-203.
19. J.M. Arsuaga, A. Sotto, M.J. López-Muñoz and L. Braeken, Influence of type and position of functional groups of phenolic compounds on NF/RO performance, J. Membr. Sci., 372 (2011) 380-386.
20. C. Bellona, J. Drewes, P. Xu and G. Amy, Factors affecting the rejection of organic solutes during NF/RO treatment-a litera ture review, Water Res., 38 (2004) 2795-2809.